EUVIMEDEUVIMED entdecken
Open Access

PPARα activation partially drives NAFLD development in liver-specific Hnf4a -null mice

Carlos Ichiro Kasano-Camones, Masayuki Takizawa, Noriyasu Ohshima, Chinatsu Saito, Wakana Iwasaki, Yuko Nakagawa, Yoshio Fujitani, Ryo Yoshida, Yoshifumi Saito, Takashi Izumi, Shin-Ichi Terawaki, Masakiyo Sakaguchi und 2 weitere

The Journal of Biochemistry · 2023

DOI: 10.1093/jb/mvad005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Biochemistry, 2023. Verfasst von Carlos Ichiro Kasano-Camones und 13 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Metabolism, Division of Molecular Science, Graduate School of Science and Technology, Gunma University, Kiryu, Gunma 376-8515, Japan. Hauptthemen laut MEDLINE: Hepatocyte Nuclear Factor 4, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Ministry of Education, Culture, Sports, Science and Technology, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

HNF4α regulates various genes to maintain liver function. There have been reports linking HNF4α expression to the development of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis. In this study, liver-specific Hnf4a-deficient mice (Hnf4aΔHep mice) developed hepatosteatosis and liver fibrosis, and they were found to have difficulty utilizing glucose. In Hnf4aΔHep mice, the expression of fatty acid oxidation-related genes, which are PPARα target genes, was increased in contrast to the decreased expression of PPARα, suggesting that Hnf4aΔHep mice take up more lipids in the liver instead of glucose. Furthermore, Hnf4aΔHep/Ppara−/− mice, which are simultaneously deficient in HNF4α and PPARα, showed improved hepatosteatosis and fibrosis. Increased C18:1 and C18:1/C18:0 ratio was observed in the livers of Hnf4aΔHep mice, and the transactivation of PPARα target gene was induced by C18:1. When the C18:1/C18:0 ratio was close to that of Hnf4aΔHep mouse liver, a significant increase in transactivation was observed. In addition, the expression of Pgc1a, a coactivator of PPARs, was increased, suggesting that elevated C18:1 and Pgc1a expression could contribute to PPARα activation in Hnf4aΔHep mice. These insights may contribute to the development of new diagnostic and therapeutic approaches for NAFLD by focusing on the HNF4α and PPARα signaling cascade.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatocyte Nuclear Factor 4Non-alcoholic Fatty Liver DiseaseAnimalsMiceLipid MetabolismLiverLiver CirrhosisMice, Inbred C57BLPPAR alpha

Stichwörter der Autor:innen

Fatty acidLipidLiverNuclear receptorSteatohepatitis

Substanzen

Hepatocyte Nuclear Factor 4Hnf4a protein, mousePPAR alpha

Autor:innen und Institutionen

  • Laboratory of Metabolism, Division of Molecular Science, Graduate School of Science and Technology, Gunma University, Kiryu, Gunma 376-8515, Japan.
  • Department of Biochemistry, Graduate School of Medicine, Gunma University, Maebashi 371-8511, Japan.
  • Laboratory of Developmental Biology and Metabolism, Institute for Molecular and Cellular Regulation, Gunma University, Maebashi, Gunma 371-8512, Japan.
  • Faculty of Health Care, Teikyo Heisei University, Tokyo 170-8445, Japan.
  • Department of Cell Biology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.
  • Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20852, USA.

Förderung

  • Ministry of Education, Culture, Sports, Science and Technology
  • National Institutes of Health

Zitieren

APA

Kasano-Camones, C. I., Takizawa, M., Ohshima, N., Saito, C., Iwasaki, W., Nakagawa, Y., Fujitani, Y., Yoshida, R., Saito, Y., Izumi, T., Terawaki, S. I., Sakaguchi, M., Gonzalez, F. J., & Inoue, Y. (2023). PPARα activation partially drives NAFLD development in liver-specific Hnf4a -null mice. The Journal of Biochemistry. https://doi.org/10.1093/jb/mvad005

Vancouver

Kasano-Camones CI, Takizawa M, Ohshima N, Saito C, Iwasaki W, Nakagawa Y, et al. PPARα activation partially drives NAFLD development in liver-specific Hnf4a -null mice. The Journal of Biochemistry. 2023. doi:10.1093/jb/mvad005

BibTeX
@article{KasanoCamones2023,
  author = {Kasano-Camones, Carlos Ichiro and Takizawa, Masayuki and Ohshima, Noriyasu and Saito, Chinatsu and Iwasaki, Wakana and Nakagawa, Yuko and Fujitani, Yoshio and Yoshida, Ryo and Saito, Yoshifumi and Izumi, Takashi and Terawaki, Shin-Ichi and Sakaguchi, Masakiyo and Gonzalez, Frank J and Inoue, Yusuke},
  title = {PPARα activation partially drives NAFLD development in liver-specific Hnf4a -null mice},
  journal = {The Journal of Biochemistry},
  year = {2023},
  doi = {10.1093/jb/mvad005}
}
Kostenlos starten →